We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Justice Department searched Perrigo’s corporate offices as part of a broad investigation into pharmaceutical industry drug pricing practices involving several companies. Read More
Pfizer called for the invalidation of three Rituxan patents covering treatments for non-Hodgkin lymphomas last week, filing separate complaints with the PTO’s patent review board. Read More
More than a dozen states are considering drug price transparency bills — most recently in California, where a state senate committee voted to advance legislation requiring drugmakers to disclose operating costs. Read More
The U.S. Supreme Court heard oral arguments Tuesday over the jurisdiction for injury cases against Bristol-Myers Squibb related to its Plavix blood thinner. Read More
In a lawsuit filed Monday, Sanofi says Mylan’s anticompetitive business practices blocked its EpiPen competitor, the Auvi-Q, from gaining a foothold in the epinephrine auto-injector market, resulting in hundreds of millions in lost sales. Read More
A California prosecutor is suing Boehringer Ingelheim and a Teva subsidiary, saying their $120 million agreement to push back the release of a generic Aggrenox blood thinner illegally delayed market competition for over seven years. Read More